Asuthkar et al. (2012) also showed that miR-211 overexpression and shRNA specific for MMP9 (pM) treatments was associated with anti-proliferative and apoptotic signaling in 4910 cancer stem cells and U87 glioma cells. Here, MMP9 is linked to central nervous system cancer.